CHICAGO (MedPage Today) -- Survival in metastatic colorectal cancer increased significantly despite no slowing of tumor growth when one targeted agent was added to chemotherapy but not another, data from a large randomized trial showed. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment